Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Neoplasm Metastasis 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Agnosia 1

Interventions

Magnetic Resonance Spectroscopy 4pembrolizumab 2Radiotherapy 2Radiosurgery 2Positron Emission Tomography Computed Tomography 2Ipilimumab 2Cyclophosphamide 2tislelizumab 1teprotumumab 1pazopanib 1lenvatinib 1gallium citrate 1fludarabine phosphate 1fludarabine 1evolocumab 1dexamethasone acetate 1dexamethasone 21-phosphate 1cabozantinib 1auricularum 1aldesleukin 1Spectrum Analysis 1Specimen Handling 1Pemetrexed 1Oxymorphone 1Oxycodone 1Nivolumab 1Morphine 1Levorphanol 1Lapatinib 1Hydromorphone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Neoplasm Metastasis × Oxycodone × Clear all
NCT03579446 2025-08-03

Levorphanol as a Second Line Opioid in Reducing Pain in Patients With Cancer

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Terminated
43 enrolled
Other hematologic neoplasm

Neoplasm Metastasis, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡